MY171137A - Thioguanine derivatives - Google Patents

Thioguanine derivatives

Info

Publication number
MY171137A
MY171137A MYPI2014002618A MYPI2014002618A MY171137A MY 171137 A MY171137 A MY 171137A MY PI2014002618 A MYPI2014002618 A MY PI2014002618A MY PI2014002618 A MYPI2014002618 A MY PI2014002618A MY 171137 A MY171137 A MY 171137A
Authority
MY
Malaysia
Prior art keywords
thioguanine
derivatives
thioguanine derivatives
directed
treatment
Prior art date
Application number
MYPI2014002618A
Inventor
A WAHAB Habibah
Hariono Maywan
Mei Lan Tan
Ezleen Binti KAMARULZAMAN Ezatul
Original Assignee
Univ Sains Malaysia
Malaysian Inst Of Pharmaceuticals & Nutraceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Sains Malaysia, Malaysian Inst Of Pharmaceuticals & Nutraceuticals filed Critical Univ Sains Malaysia
Priority to MYPI2014002618A priority Critical patent/MY171137A/en
Priority to PCT/IB2015/056933 priority patent/WO2016038562A1/en
Publication of MY171137A publication Critical patent/MY171137A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/24—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one nitrogen and one sulfur atom

Abstract

The present invention is directed to use of thioguanine derivatives and their use in the treatment of dengue fever or West Nile virus.
MYPI2014002618A 2014-09-11 2014-09-11 Thioguanine derivatives MY171137A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MYPI2014002618A MY171137A (en) 2014-09-11 2014-09-11 Thioguanine derivatives
PCT/IB2015/056933 WO2016038562A1 (en) 2014-09-11 2015-09-10 Thioguanine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2014002618A MY171137A (en) 2014-09-11 2014-09-11 Thioguanine derivatives

Publications (1)

Publication Number Publication Date
MY171137A true MY171137A (en) 2019-09-27

Family

ID=55458407

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2014002618A MY171137A (en) 2014-09-11 2014-09-11 Thioguanine derivatives

Country Status (2)

Country Link
MY (1) MY171137A (en)
WO (1) WO2016038562A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114716439B (en) * 2022-04-26 2023-08-15 陕西师范大学 Method for synthesizing 6-thiopurine derivative by copper catalysis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB836696A (en) * 1955-06-22 1960-06-09 Wellcome Found Improvements in and relating to derivatives of purine and the manufacture thereof
JPS62207271A (en) * 1986-03-06 1987-09-11 Yamanouchi Pharmaceut Co Ltd Condensed ring compound substituted with 2-pyridylmethylthio group or 2-pyridylmethylsulfinyl group
CN1646141B (en) * 2000-10-18 2014-06-25 吉利德制药有限责任公司 Modified nucleosides for treatment of viral infections and abnormal cellular proliferation
WO2005018330A1 (en) * 2003-08-18 2005-03-03 Pharmasset, Inc. Dosing regimen for flaviviridae therapy
WO2008033466A2 (en) * 2006-09-14 2008-03-20 Combinatorx (Singapore) Pre. Ltd. Compositions and methods for treatment of viral diseases
WO2013036749A1 (en) * 2011-09-07 2013-03-14 University Of Kansas Hcv helicase inhibitors and methods of use thereof
EP2755693A4 (en) * 2011-09-12 2015-05-20 Moderna Therapeutics Inc Engineered nucleic acids and methods of use thereof

Also Published As

Publication number Publication date
WO2016038562A1 (en) 2016-03-17

Similar Documents

Publication Publication Date Title
MX2020009461A (en) Anti-pvrig antibodies and methods of use.
EA201791460A1 (en) N4-HYDROXYCYTIDINE AND RELATED DERIVATIVES AND OPTIONS FOR ANTI-VIRUS APPLICATION
CL2016002123A1 (en) New polysaccharide and uses thereof
ZA201608077B (en) Combination, composition, and method of administering the combination or composition to animals
EA201790737A1 (en) COMBINED THERAPY
CL2016002027A1 (en) Cyclopropylamine as an inhibitor of lsd1
EA201692098A1 (en) BIOCERAMIC COMPOSITIONS AND THEIR APPLICATION FOR BIOMODULATION
PH12016502468A1 (en) Influenza virus vaccines and uses thereof
DK3212208T3 (en) USE OF L. REUTERI FOR PREVENTION OR TREATMENT OF MICROBIOTADYSBIOSIS EARLY IN LIFE
EA201692529A1 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF DISORDERS USING FOLLYSTATINE POLYPEPTIDES
MX2016017108A (en) Personal care compositions and methods.
EA201692552A1 (en) MODIFIED MENICOCCOKED POLYPEPTIDES fHbp
MX2020004419A (en) Modified meningococcal fhbp polypeptides.
PH12017500836A1 (en) Transdermal formulations
MY187261A (en) Influenza virus vaccines and uses thereof
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
MX2017006019A (en) Apilimod for use in the treatment of melanoma.
AU360105S (en) Aircraft stick grip
DK3153511T3 (en) 2-ACYLAMINOTHIAZERER DERIVATIVES FOR USE IN THE PREVENTION OR TREATMENT OF BLOWER AND URINAL DISEASES
PH12016501434A1 (en) Compositions for use in the treatment of allergic conditions
SG11201704942QA (en) Dengue virus vaccine compositions and methods of use thereof
MX2019010913A (en) Analogs of deutetrabenazine, their preparation and use.
DK3164123T3 (en) Novel uses of benzylideneguanidine derivatives in the treatment of proteopathies
MY171137A (en) Thioguanine derivatives
EA201890209A1 (en) COMPOSITION CONTAINING TANINS